Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Inebilizumab Biosimilar – Anti-CD19 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG1, kappa

€200.00

100ug + 200 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
SDS-PAGE for Inebilizumab Biosimilar - Anti-CD19 mAb

Inebilizumab Biosimilar - Anti-CD19 mAb - Research Grade

Product name Inebilizumab Biosimilar - Anti-CD19 mAb - Research Grade
Source CAS 1299440-37-1
Species Humanized
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Inebilizumab,MEDI-551,CD19,anti-CD19
Reference PX-TA1385
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody
Product name Inebilizumab Biosimilar - Anti-CD19 mAb - Research Grade
Source CAS 1299440-37-1
Species Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Inebilizumab,MEDI-551,CD19,anti-CD19
Reference PX-TA1385
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody

General information on Anti-CD19[Homo sapiens] (Inebilizumab) Monoclonal Antibody

Inebilizumab is a humanized afucosylated monoclonal IgG1 antibody that targets the broadly expressed B-cell surface antigen CD19. Inebilizumab is cytolytic, which may be usefull to treat neuromyelitis optica spectrum disorder (NMOSD)through B-cell depletion.

SDS-PAGE for Inebilizumab Biosimilar - Anti-CD19 mAb

SDS-PAGE for Inebilizumab Biosimilar - Anti-CD19 mAb

Inebilizumab Biosimilar - Anti-CD19 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

There are no reviews yet.

Be the first to review “Inebilizumab Biosimilar – Anti-CD19 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products